An investigator initiated, phase II open-label study of Autologous-bone-marrow-derived-mesenchymal-stem-cells in patients with spinal cord injury
Latest Information Update: 07 Apr 2021
At a glance
- Drugs Autologous bone marrow derived mesenchymal stem cells-Nipro Corproration/Sapporo Medical University (Primary)
- Indications Spinal cord injuries
- Focus Therapeutic Use
- 07 Apr 2021 New trial record